Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.
Summary
Bill S06851, known as the Collaborative Practice Medication Adherence Act, aims to amend the public health law and the education law in New York to establish permanent provisions for collaborative practice medication adherence between pharmacists and physicians. The bill defines the roles and responsibilities of qualified pharmacists in managing medication adherence for patients with chronic diseases, allowing them to adjust drug regimens and consult with physicians under established protocols. This collaborative approach is intended to enhance patient care by ensuring that medications are appropriate, effective, and safe for individual patients.
Impact
The bill will have a significant impact on state laws by formalizing the collaborative practice between pharmacists and physicians, thereby expanding the scope of practice for pharmacists in managing chronic diseases. It establishes a framework for creating collaborative practice medication adherence protocols, which will be subject to review by the Department of Health. This change aims to improve healthcare outcomes by facilitating better medication management and adherence for patients, potentially reducing hospitalizations and improving overall health management.
Sentiment
The sentiment surrounding Bill S06851 appears to be overwhelmingly positive, as indicated by the unanimous votes in the Senate Health Committee, Senate Rules Committee, and the final Senate floor vote. The discussions leading up to the votes suggest strong support for enhancing collaborative healthcare practices, with no recorded opposition during the voting process.
Contention
There are no notable points of contention reported in the discussions or voting history for Bill S06851. The bill has received unanimous support in all committee and floor votes, indicating a consensus among legislators regarding the benefits of collaborative practice medication adherence.
Same As
Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.
Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.
Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.
Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”
Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”
Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”
Permits licensed pharmacists and nurse practitioners to prescribe and order COVID-19 immunizations; permits physicians to issue non-patient specific orders to pharmacists for COVID-19 immunizations for patients two years of age and older; permits pharmacists to issue patient specific orders for COVID-19 immunizations for patients two years of age and older.
Permits licensed pharmacists and nurse practitioners to prescribe and order COVID-19 immunizations; permits physicians to issue non-patient specific orders to pharmacists for COVID-19 immunizations for patients two years of age and older; permits pharmacists to issue patient specific orders for COVID-19 immunizations for patients two years of age and older.